4.7 Article

Association of Tirofiban With Functional Outcomes After Thrombectomy in Acute Ischemic Stroke Due to Intracranial Atherosclerotic Disease

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke The RESCUE BT Randomized Clinical Trial

Zhongming Qiu et al.

Summary: This study assessed the efficacy and adverse events of intravenous tirofiban before endovascular thrombectomy for acute ischemic stroke secondary to large vessel occlusion. The findings showed no significant difference in disability severity at 90 days between the tirofiban and placebo groups, suggesting that intravenous tirofiban may not be beneficial for acute ischemic stroke patients undergoing endovascular therapy.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Review Clinical Neurology

Safety and efficacy of tirofiban combined with endovascular therapy compared with endovascular therapy alone in acute ischemic stroke: a meta-analysis

Yingying Sun et al.

Summary: The meta-analysis evaluated the safety and efficacy of tirofiban combined with EVT for treating AIS, showing that this treatment did not increase the risks of symptomatic intracranial hemorrhage or mortality, but was associated with significantly improved functional outcomes in AIS patients.

NEURORADIOLOGY (2021)

Article Medicine, General & Internal

Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial

Wenjie Zi et al.

Summary: This study showed that endovascular treatment alone was noninferior to combined intravenous alteplase and endovascular treatment in achieving functional independence at 90 days among patients with ischemic stroke due to proximal anterior circulation occlusion within 4.5 hours from onset, with no significant differences in safety outcomes.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Clinical Neurology

Intravenous Tirofiban Infusion After Angioplasty and Stenting in Intracranial Atherosclerotic Stenosis-Related Stroke

Byung Hyun Baek et al.

Summary: In patients with intracranial atherosclerotic stenosis-related large-vessel occlusion stroke, postprocedural intravenous infusion of tirofiban for 12 hours was found to reduce the risk of early reocclusion without increasing hemorrhage risk. Early reocclusion was associated with a poor outcome.

STROKE (2021)

Article Clinical Neurology

Low-dose rescue tirofiban in mechanical thrombectomy for acute cerebral large-artery occlusion

M. Yang et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Review Urology & Nephrology

Intention to treat and per protocol analysis in clinical trials

Giovanni Tripepi et al.

NEPHROLOGY (2020)

Article Neuroimaging

eTICI reperfusion: defining success in endovascular stroke therapy

David S. Liebeskind et al.

JOURNAL OF NEUROINTERVENTIONAL SURGERY (2019)

Article Cardiac & Cardiovascular Systems

Impact of Procedure Time on Outcomes of Thrombectomy for Stroke

Ali Alawieh et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Review Clinical Neurology

Stroke in Asia: geographical variations and temporal trends

Man Mohan Mehndiratta et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Review Clinical Neurology

Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment

Christine A. Holmstedt et al.

LANCET NEUROLOGY (2013)

Article Clinical Neurology

An evidence-based causative classification system for acute ischemic stroke

H Ay et al.

ANNALS OF NEUROLOGY (2005)

Article Health Care Sciences & Services

Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test

ST Brookes et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)